was read the article
array:25 [ "pii" => "S0021755717305399" "issn" => "00217557" "doi" => "10.1016/j.jped.2017.06.002" "estado" => "S300" "fechaPublicacion" => "2017-11-01" "aid" => "520" "copyright" => "Sociedade Brasileira de Pediatria" "copyrightAnyo" => "2017" "documento" => "article" "crossmark" => 1 "licencia" => "http://creativecommons.org/licenses/by-nc-nd/4.0/" "subdocumento" => "rev" "cita" => "J Pediatr (Rio J). 2017;93 Supl 1:19-25" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:2 [ "total" => 946 "formatos" => array:3 [ "EPUB" => 87 "HTML" => 481 "PDF" => 378 ] ] "Traduccion" => array:1 [ "pt" => array:20 [ "pii" => "S2255553617300897" "issn" => "22555536" "doi" => "10.1016/j.jpedp.2017.08.007" "estado" => "S300" "fechaPublicacion" => "2017-11-01" "aid" => "520" "copyright" => "Sociedade Brasileira de Pediatria" "documento" => "article" "crossmark" => 1 "licencia" => "http://creativecommons.org/licenses/by-nc-nd/4.0/" "subdocumento" => "rev" "cita" => "J Pediatr (Rio J). 2017;93 Supl 1:19-25" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:2 [ "total" => 1211 "formatos" => array:3 [ "EPUB" => 90 "HTML" => 847 "PDF" => 274 ] ] "pt" => array:13 [ "idiomaDefecto" => true "cabecera" => "<span class="elsevierStyleTextfn">Artigo de revisão</span>" "titulo" => "Magnesium sulfate infusion for acute asthma in the emergency department" "tienePdf" => "pt" "tieneTextoCompleto" => "pt" "tieneResumen" => array:2 [ 0 => "en" 1 => "pt" ] "paginas" => array:1 [ 0 => array:2 [ "paginaInicial" => "19" "paginaFinal" => "25" ] ] "titulosAlternativos" => array:1 [ "pt" => array:1 [ "titulo" => "Infusão de sulfato de magnésio para asma aguda no serviço de emergência" ] ] "contieneResumen" => array:2 [ "en" => true "pt" => true ] "contieneTextoCompleto" => array:1 [ "pt" => true ] "contienePdf" => array:1 [ "pt" => true ] "resumenGrafico" => array:2 [ "original" => 0 "multimedia" => array:7 [ "identificador" => "fig0005" "etiqueta" => "Figura 1" "tipo" => "MULTIMEDIAFIGURA" "mostrarFloat" => true "mostrarDisplay" => false "figura" => array:1 [ 0 => array:4 [ "imagen" => "gr1.jpeg" "Alto" => 1022 "Ancho" => 1342 "Tamanyo" => 50178 ] ] "descripcion" => array:1 [ "pt" => "<p id="spar0045" class="elsevierStyleSimplePara elsevierViewall">Percentual de pacientes com alta do SE por grupo; 50<span class="elsevierStyleHsp" style=""></span>mg/kg/1 hora em bólus, 200<span class="elsevierStyleHsp" style=""></span>mg/kg/por quatro horas de HDMI. As colunas representam os pacientes com alta por grupo, alta dose de infusão de magnésio.</p>" ] ] ] "autores" => array:1 [ 0 => array:2 [ "autoresLista" => "Jose Enrique Irazuzta, Nicolas Chiriboga" "autores" => array:2 [ 0 => array:2 [ "nombre" => "Jose Enrique" "apellidos" => "Irazuzta" ] 1 => array:2 [ "nombre" => "Nicolas" "apellidos" => "Chiriboga" ] ] ] ] ] "idiomaDefecto" => "pt" "Traduccion" => array:1 [ "en" => array:9 [ "pii" => "S0021755717305399" "doi" => "10.1016/j.jped.2017.06.002" "estado" => "S300" "subdocumento" => "" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:1 [ "total" => 0 ] "idiomaDefecto" => "en" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S0021755717305399?idApp=UINPBA000049" ] ] "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S2255553617300897?idApp=UINPBA000049" "url" => "/22555536/00000093000000S1/v1_201711120039/S2255553617300897/v1_201711120039/pt/main.assets" ] ] "itemSiguiente" => array:19 [ "pii" => "S0021755717304862" "issn" => "00217557" "doi" => "10.1016/j.jped.2017.06.003" "estado" => "S300" "fechaPublicacion" => "2017-11-01" "aid" => "521" "documento" => "article" "crossmark" => 1 "licencia" => "http://creativecommons.org/licenses/by-nc-nd/4.0/" "subdocumento" => "rev" "cita" => "J Pediatr (Rio J). 2017;93 Supl 1:26-35" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:2 [ "total" => 1002 "formatos" => array:3 [ "EPUB" => 104 "HTML" => 651 "PDF" => 247 ] ] "en" => array:13 [ "idiomaDefecto" => true "cabecera" => "<span class="elsevierStyleTextfn">Review article</span>" "titulo" => "Assessment of acute motor deficit in the pediatric emergency room" "tienePdf" => "en" "tieneTextoCompleto" => "en" "tieneResumen" => array:2 [ 0 => "en" 1 => "pt" ] "paginas" => array:1 [ 0 => array:2 [ "paginaInicial" => "26" "paginaFinal" => "35" ] ] "titulosAlternativos" => array:1 [ "pt" => array:1 [ "titulo" => "Avaliação do déficit motor agudo no ambiente de pronto socorro pediátrico" ] ] "contieneResumen" => array:2 [ "en" => true "pt" => true ] "contieneTextoCompleto" => array:1 [ "en" => true ] "contienePdf" => array:1 [ "en" => true ] "resumenGrafico" => array:2 [ "original" => 0 "multimedia" => array:7 [ "identificador" => "fig0010" "etiqueta" => "Figure 2" "tipo" => "MULTIMEDIAFIGURA" "mostrarFloat" => true "mostrarDisplay" => false "figura" => array:1 [ 0 => array:4 [ "imagen" => "gr2.jpeg" "Alto" => 2174 "Ancho" => 3326 "Tamanyo" => 503945 ] ] "descripcion" => array:1 [ "en" => "<p id="spar0055" class="elsevierStyleSimplePara elsevierViewall">Algorithm for acute diffuse weakness investigation in the emergency setting.</p> <p id="spar0060" class="elsevierStyleSimplePara elsevierViewall">AChR, acetylcholine receptor; CK, serum creatine-kinase; CNS, central nervous system; CSF, cerebrospinal fluid; EEG, electroencephalography; EMG, electromyography; GBS, Guillain–Barré syndrome; Hx, history; IgG, immunoglobulin G; K<span class="elsevierStyleSup">+</span>, serum potassium; MS, multiple sclerosis; NMO, neuromyelitis optica; PE, physical examination; PRES, posterior reversible encephalopathy syndrome; RHS, Ramsay-Hunt syndrome; T<span class="elsevierStyleInf">4</span>, thyroxine; w/o, without.</p> <p id="spar0065" class="elsevierStyleSimplePara elsevierViewall"><span class="elsevierStyleSup">a</span>A cause of pseudoparalysis.</p> <p id="spar0070" class="elsevierStyleSimplePara elsevierViewall"><span class="elsevierStyleSup">b</span>Myelopathy signs include a sensory level, bladder and/or bowel dysfunction, and paraplegia or tetraplegia.</p>" ] ] ] "autores" => array:1 [ 0 => array:2 [ "autoresLista" => "Marcio Moacyr Vasconcelos, Luciana G.A. Vasconcelos, Adriana Rocha Brito" "autores" => array:3 [ 0 => array:2 [ "nombre" => "Marcio Moacyr" "apellidos" => "Vasconcelos" ] 1 => array:2 [ "nombre" => "Luciana G.A." "apellidos" => "Vasconcelos" ] 2 => array:2 [ "nombre" => "Adriana Rocha" "apellidos" => "Brito" ] ] ] ] ] "idiomaDefecto" => "en" "Traduccion" => array:1 [ "pt" => array:9 [ "pii" => "S2255553617300903" "doi" => "10.1016/j.jpedp.2017.08.008" "estado" => "S300" "subdocumento" => "" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:1 [ "total" => 0 ] "idiomaDefecto" => "pt" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S2255553617300903?idApp=UINPBA000049" ] ] "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S0021755717304862?idApp=UINPBA000049" "url" => "/00217557/00000093000000S1/v1_201711110016/S0021755717304862/v1_201711110016/en/main.assets" ] "itemAnterior" => array:20 [ "pii" => "S0021755717303959" "issn" => "00217557" "doi" => "10.1016/j.jped.2017.07.009" "estado" => "S300" "fechaPublicacion" => "2017-11-01" "aid" => "570" "copyright" => "Sociedade Brasileira de Pediatria" "documento" => "article" "crossmark" => 1 "licencia" => "http://creativecommons.org/licenses/by-nc-nd/4.0/" "subdocumento" => "rev" "cita" => "J Pediatr (Rio J). 2017;93 Supl 1:2-18" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:2 [ "total" => 860 "formatos" => array:3 [ "EPUB" => 82 "HTML" => 531 "PDF" => 247 ] ] "en" => array:13 [ "idiomaDefecto" => true "cabecera" => "<span class="elsevierStyleTextfn">Review article</span>" "titulo" => "Sedation and analgesia for procedures in the pediatric emergency room" "tienePdf" => "en" "tieneTextoCompleto" => "en" "tieneResumen" => array:2 [ 0 => "en" 1 => "pt" ] "paginas" => array:1 [ 0 => array:2 [ "paginaInicial" => "2" "paginaFinal" => "18" ] ] "titulosAlternativos" => array:1 [ "pt" => array:1 [ "titulo" => "Sedação e analgesia para procedimentos no pronto-socorro de pediatria" ] ] "contieneResumen" => array:2 [ "en" => true "pt" => true ] "contieneTextoCompleto" => array:1 [ "en" => true ] "contienePdf" => array:1 [ "en" => true ] "resumenGrafico" => array:2 [ "original" => 0 "multimedia" => array:7 [ "identificador" => "fig0020" "etiqueta" => "Figure 4" "tipo" => "MULTIMEDIAFIGURA" "mostrarFloat" => true "mostrarDisplay" => false "figura" => array:1 [ 0 => array:4 [ "imagen" => "gr4.jpeg" "Alto" => 414 "Ancho" => 1568 "Tamanyo" => 35590 ] ] "descripcion" => array:1 [ "en" => "<p id="spar0060" class="elsevierStyleSimplePara elsevierViewall">Visual analog scale. Adapted from McCaffery et al.<a class="elsevierStyleCrossRef" href="#bib0845"><span class="elsevierStyleSup">21</span></a> Simple numerical scale. Ask the patient to indicate the intensity of the current, the best and the worst level of pain in the last 24<span class="elsevierStyleHsp" style=""></span>h on a scale of 0 (no pain) to 10 (worst pain imaginable).</p>" ] ] ] "autores" => array:1 [ 0 => array:2 [ "autoresLista" => "Carlos Eduardo Ramalho, Pedro Messeder Caldeira Bretas, Claudio Schvartsman, Amélia Gorete Reis" "autores" => array:4 [ 0 => array:2 [ "nombre" => "Carlos Eduardo" "apellidos" => "Ramalho" ] 1 => array:2 [ "nombre" => "Pedro Messeder Caldeira" "apellidos" => "Bretas" ] 2 => array:2 [ "nombre" => "Claudio" "apellidos" => "Schvartsman" ] 3 => array:2 [ "nombre" => "Amélia Gorete" "apellidos" => "Reis" ] ] ] ] ] "idiomaDefecto" => "en" "Traduccion" => array:1 [ "pt" => array:9 [ "pii" => "S2255553617301507" "doi" => "10.1016/j.jpedp.2017.05.006" "estado" => "S300" "subdocumento" => "" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:1 [ "total" => 0 ] "idiomaDefecto" => "pt" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S2255553617301507?idApp=UINPBA000049" ] ] "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S0021755717303959?idApp=UINPBA000049" "url" => "/00217557/00000093000000S1/v1_201711110016/S0021755717303959/v1_201711110016/en/main.assets" ] "en" => array:20 [ "idiomaDefecto" => true "cabecera" => "<span class="elsevierStyleTextfn">Review article</span>" "titulo" => "Magnesium sulfate infusion for acute asthma in the emergency department" "tieneTextoCompleto" => true "paginas" => array:1 [ 0 => array:2 [ "paginaInicial" => "19" "paginaFinal" => "25" ] ] "autores" => array:1 [ 0 => array:4 [ "autoresLista" => "Jose Enrique Irazuzta, Nicolas Chiriboga" "autores" => array:2 [ 0 => array:4 [ "nombre" => "Jose Enrique" "apellidos" => "Irazuzta" "email" => array:1 [ 0 => "Jose.Irazuzta@jax.ufl.edu" ] "referencia" => array:3 [ 0 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">a</span>" "identificador" => "aff0005" ] 1 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">b</span>" "identificador" => "aff0010" ] 2 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">*</span>" "identificador" => "cor0005" ] ] ] 1 => array:3 [ "nombre" => "Nicolas" "apellidos" => "Chiriboga" "referencia" => array:2 [ 0 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">a</span>" "identificador" => "aff0005" ] 1 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">b</span>" "identificador" => "aff0010" ] ] ] ] "afiliaciones" => array:2 [ 0 => array:3 [ "entidad" => "Wolfson Children's Hospital, Jacksonville, United States" "etiqueta" => "a" "identificador" => "aff0005" ] 1 => array:3 [ "entidad" => "University of Florida, Jacksonville, United States" "etiqueta" => "b" "identificador" => "aff0010" ] ] "correspondencia" => array:1 [ 0 => array:3 [ "identificador" => "cor0005" "etiqueta" => "⁎" "correspondencia" => "Corresponding author." ] ] ] ] "titulosAlternativos" => array:1 [ "pt" => array:1 [ "titulo" => "Infusão de sulfato de magnésio para asma aguda no serviço de emergência" ] ] "resumenGrafico" => array:2 [ "original" => 0 "multimedia" => array:7 [ "identificador" => "fig0005" "etiqueta" => "Figure 1" "tipo" => "MULTIMEDIAFIGURA" "mostrarFloat" => true "mostrarDisplay" => false "figura" => array:1 [ 0 => array:4 [ "imagen" => "gr1.jpeg" "Alto" => 1022 "Ancho" => 1342 "Tamanyo" => 49989 ] ] "descripcion" => array:1 [ "en" => "<p id="spar0045" class="elsevierStyleSimplePara elsevierViewall">Percentage of patients discharged home from the ED by group. Bolus, 50<span class="elsevierStyleHsp" style=""></span>mg/kg/1<span class="elsevierStyleHsp" style=""></span>h; HDMI, 200<span class="elsevierStyleHsp" style=""></span>mg/kg/4<span class="elsevierStyleHsp" style=""></span>h. Columns represent patients discharged, by group. HDMI, high-dose magnesium infusion.</p>" ] ] ] "textoCompleto" => "<span class="elsevierStyleSections"><span id="sec0005" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0065">Introduction</span><p id="par0005" class="elsevierStylePara elsevierViewall">Asthma is a reversible, diffuse lower airway obstruction caused by airway inflammation and edema, bronchial smooth-muscle spasm, and mucous plugging. The composite effect leads to expiratory airflow obstruction.<a class="elsevierStyleCrossRef" href="#bib0005"><span class="elsevierStyleSup">1</span></a> Asthma could be life-threatening and must be promptly treated. Severe asthma is often defined as failure to improve after 2<span class="elsevierStyleHsp" style=""></span>h of conventional emergency department (ED) treatment, and commonly present with moderate hypoxemia. The presence of hypoxemia should be assessed non-invasively with a pulse oximeter. Blood gas, serological or radiological studies are not necessary to define or determine its severity.</p><span id="sec0010" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0070">Perspective on a health challenge</span><p id="par0010" class="elsevierStylePara elsevierViewall">Asthma is the leading cause of chronic illness in children; 19–24% of Brazilian children have been diagnosed with asthma at some time in their lives.<a class="elsevierStyleCrossRef" href="#bib0010"><span class="elsevierStyleSup">2</span></a> It is the third leading cause of hospitalizations among children under the age of 15 years. Severe asthma is one of the most common severe, reversible conditions in EDs.<a class="elsevierStyleCrossRefs" href="#bib0005"><span class="elsevierStyleSup">1,2</span></a> While asthma-related mortality may be improving, one-third of the deaths occurred before medical attention was provided.<a class="elsevierStyleCrossRef" href="#bib0015"><span class="elsevierStyleSup">3</span></a> ED management to revers the progression toward respiratory failure should be structured and aggressive, as invasive mechanical ventilation is fraught with many complications and an elevated mortality.<a class="elsevierStyleCrossRef" href="#bib0020"><span class="elsevierStyleSup">4</span></a> Due to the enormous health care burden of asthma, all medical treatments need to be scrutinized regarding their cost-effectiveness.</p></span><span id="sec0015" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0075">Pathophysiology</span><p id="par0015" class="elsevierStylePara elsevierViewall">Asthma involves a complex inflammatory cascade. There is an antigen-mediated activation of epithelial cells and infiltration of the airways by circulating cells releasing soluble transmitters that intensify the inflammatory cascade. The immediate response is bronchospasm (smooth muscle contraction). The continued release of inflammatory mediators leads to airway edema, mucosal injury, and desquamation of the protective epithelium layer. Airway denudation decreases the production of normal mucus and exposes the terminal nerves to excessive cholinergic stimulation, exacerbating smooth muscle contraction.<a class="elsevierStyleCrossRef" href="#bib0025"><span class="elsevierStyleSup">5</span></a></p><p id="par0020" class="elsevierStylePara elsevierViewall">The progression of this physiopathology results in widespread lung heterogeneity with severe bronchoconstriction. Lung areas with mucus plugging and atelectasis alternate with areas of hyperinflation due to air trapping. The combined effects of the aforementioned processes lead to ventilation perfusion mismatch (V/Q mismatch), with the clinical expression of hypoxemia. Air trapping puts the diaphragm in a disadvantageous position, losing its area of apposition and producing an ineffective effort. The respiratory work load increases dramatically, and inspiratory substernal retractions are observed, progressing to a paradoxical thoraco-abdominal breathing pattern. In severe cases, the cardiac output is compromised, with a combination of dehydration, increased pulmonary venous pressure creating a dynamic decreased venous return to the right atrium, and a shift of the intraventricular septum, impinging the left ventricle preload.</p></span><span id="sec0020" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0080">Clinical presentation</span><p id="par0025" class="elsevierStylePara elsevierViewall">The majority of severe asthma exacerbations occur after an exposure to allergic triggers or in the setting of a viral upper respiratory infection. Most children present with cough, wheezing, prolonged expiratory phase, and increased work of breathing while under mild hypoxemic conditions and dehydration. The degree of wheezing does not correlate well with severity of the disease. Clinical asthma scoring systems, such as the Woods score, lack granularity, but are helpful in patient follow-up.<a class="elsevierStyleCrossRef" href="#bib0030"><span class="elsevierStyleSup">6</span></a> This and other clinical scores express categorical variables (mild/moderate/severe) as a number,<a class="elsevierStyleCrossRefs" href="#bib0005"><span class="elsevierStyleSup">1–3</span></a> which facilitates the trending of acuity on a single patient; nonetheless, any statistical analysis of these results should be performed as categorical variable. Peak expiratory flow rate (PEFR), in cooperative previously-trained patients, provides a more granular assessment. However, it is an effort-dependent technique and difficult to perform while in respiratory distress, unless the investigators are previously trained to perform spirometry testing.<a class="elsevierStyleCrossRef" href="#bib0035"><span class="elsevierStyleSup">7</span></a> The presence of pulsus paradoxus denotes severity, but it is difficult to be repeatedly assessed in a busy ED.</p></span><span id="sec0025" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0085">Initial ED management</span><p id="par0030" class="elsevierStylePara elsevierViewall">An organized and resolute ED initial management is needed, due to the compounded facts that severe asthma is: (a) a condition with a high incidence, (b) has a potential for reversibility, (c) has the risk to progress toward respiratory failure, and (d) the ED needs to judiciously manage hospital admission. The primary goal is to stabilize patients and rapidly identify those in whom the process is not rapidly reversible or who are at a high risk of deterioration.</p><p id="par0035" class="elsevierStylePara elsevierViewall">The initial treatments include oxygen, intravenous fluids, intravenous or oral corticosteroid, repeated or continuous nebulization of a β<span class="elsevierStyleInf">2</span> adrenergic (<span class="elsevierStyleItalic">i.e.</span>, salbutamol), nebulized muscarinic anticholinergic (<span class="elsevierStyleItalic">i.e.</span>, ipratropium), and intravenous MgSO<span class="elsevierStyleInf">4</span>.</p><p id="par0040" class="elsevierStylePara elsevierViewall">Failure to improve after the aforementioned regimen, assessed as persistence of respiratory distress upon clinical exam, is defined as severe asthma (or <span class="elsevierStyleItalic">status asthmaticus</span>).</p><p id="par0045" class="elsevierStylePara elsevierViewall">Methylxanthines and subcutaneous or intravenous β-agonists are not routinely utilized as a first line therapy in the United States. However, a study from Porto Alegre that assessed the effects of intravenous salbutamol in ED, observed a decrease in the β<span class="elsevierStyleInf">2</span> adrenergic nebulization requirements subsequent to the patients’ hospital admission.<a class="elsevierStyleCrossRef" href="#bib0040"><span class="elsevierStyleSup">8</span></a> That study only addressed changes in respiratory rate and did not control for alterations in other clinical findings. It also did not state whether vital signs monitoring was performed in a blinded fashion. Heliox may improve the aerosol delivery of β<span class="elsevierStyleInf">2</span> adrenergic to the lower airway; nonetheless, it is expensive and does not appear to offer a consistent and significant clinical benefit.<a class="elsevierStyleCrossRefs" href="#bib0045"><span class="elsevierStyleSup">9,10</span></a> and cost-effective studies are required. BIPAP support in the ED appears to stabilize patients with <span class="elsevierStyleItalic">status asthmaticus</span> before the hospital admission; however, the cumulative data (two publications) is scarce to recommend it as standard therapy.<a class="elsevierStyleCrossRefs" href="#bib0055"><span class="elsevierStyleSup">11,12</span></a></p><p id="par0050" class="elsevierStylePara elsevierViewall">In turn, the use of intravenous MgSO<span class="elsevierStyleInf">4</span> has emerged as a proven strategy to reduce hospital admissions. This study aimed to review the different regimens for MgSO<span class="elsevierStyleInf">4</span> administration and its contribution in the management of severe asthma.</p></span><span id="sec0030" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0090">MgSO<span class="elsevierStyleInf">4</span> mechanism of action and kinetics</span><p id="par0055" class="elsevierStylePara elsevierViewall">The primary mechanism of action of intravenous MgSO<span class="elsevierStyleInf">4</span> is thought to be secondary to its spasmolytic properties. Supra-physiologic unbound serum magnesium (Mg), directly related to ionized Mg, produces a transient block of the N-methyl-<span class="elsevierStyleSmallCaps">d</span>-aspartate receptor-gated calcium channels with subsequent muscle relaxation. Blocking the Ca entry into the airway smooth muscle interferes with smooth muscle contraction, inducing bronchodilation.<a class="elsevierStyleCrossRefs" href="#bib0065"><span class="elsevierStyleSup">13–15</span></a> While other mechanisms modulating the inflammatory reaction, such the attenuation of the neutrophil respiratory burst, have putative beneficial effects, their degree of contribution in the therapeutic management of acute asthma is less clear.<a class="elsevierStyleCrossRef" href="#bib0080"><span class="elsevierStyleSup">16</span></a> The Mg<span class="elsevierStyleSup">2+</span> ion, due to its effects on Ca, also inhibits the release of acetylcholine from motor nerve terminals, inhibiting histamine release from mast cells and decreasing the production of mucus in the secretory glands.<a class="elsevierStyleCrossRef" href="#bib0085"><span class="elsevierStyleSup">17</span></a></p><p id="par0060" class="elsevierStylePara elsevierViewall">Intravenous MgSO<span class="elsevierStyleInf">4</span> has a rapid onset of action and, similarly, a rapid renal elimination. This presents a therapeutic challenge and an opportunity. Achieving sustained spasmolytic effects is difficult, as renal tubular reabsorption of Mg is at maximal capacity with normal serum levels and renal clearance rises linearly with higher concentrations.<a class="elsevierStyleCrossRef" href="#bib0090"><span class="elsevierStyleSup">18</span></a> Therefore, the maximum serum level during therapy depends more on the rate of infusion rather than on the total dose or duration of the infusion. In children, a retrospective study described that the MgSO<span class="elsevierStyleInf">4</span> distribution volume was 0.3<span class="elsevierStyleHsp" style=""></span>L/kg, with a half-life of 2–2.7<span class="elsevierStyleHsp" style=""></span>h.<a class="elsevierStyleCrossRef" href="#bib0095"><span class="elsevierStyleSup">19</span></a> Often, the bolus dose of intravenous MgSO<span class="elsevierStyleInf">4</span> has been limited to 2000<span class="elsevierStyleHsp" style=""></span>mg, regardless of patient size and renal function. This practice is contradictory with a pharmacokinetic rationale and affects its pharmacodynamic properties.</p></span><span id="sec0035" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0095">Experience in the use of intravenous MgSO<span class="elsevierStyleInf">4</span> in asthmatic children</span><p id="par0065" class="elsevierStylePara elsevierViewall">MgSO<span class="elsevierStyleInf">4</span> is inexpensive, has minimal adverse effects at the doses indicated, and is widely available. The onset of action of intravenous MgSO<span class="elsevierStyleInf">4</span> is rapid (within minutes), a necessity in emergency settings. Since its original description in 1936, the optimal dose of IV MgSO<span class="elsevierStyleInf">4</span> as a bolus has not been established, leading to the utilization of a wide dose range, from 25 to >100<span class="elsevierStyleHsp" style=""></span>mg/kg.<a class="elsevierStyleCrossRefs" href="#bib0090"><span class="elsevierStyleSup">18–22</span></a> Multicenter studies have failed to demonstrate a consistent decrease in hospital admissions or early discharge.<a class="elsevierStyleCrossRefs" href="#bib0115"><span class="elsevierStyleSup">23–25</span></a></p><p id="par0070" class="elsevierStylePara elsevierViewall">These inconsistent results could be in part due to: (a) failure to take into consideration the MgSO<span class="elsevierStyleInf">4</span> pharmacokinetics, (b) failure to conceptualize MgSO<span class="elsevierStyleInf">4</span> as a time-sensitive therapy, (c) the inherent challenges of the aforementioned “outcome variables” in asthma, or (d) enrollment of individuals with current infectious process, with ongoing stimuli for bronchoconstriction and damage to the airway.</p><p id="par0075" class="elsevierStylePara elsevierViewall">Some clinical studies indicate the need for higher-dose regimens.<a class="elsevierStyleCrossRefs" href="#bib0110"><span class="elsevierStyleSup">22,26</span></a> Ciarallo et al. reported positive results in two clinical trials, separated by a period of four years, where the dose was increased from 25<span class="elsevierStyleHsp" style=""></span>mg/kg to 40<span class="elsevierStyleHsp" style=""></span>mg/kg, administered over 20<span class="elsevierStyleHsp" style=""></span>min.<a class="elsevierStyleCrossRef" href="#bib0110"><span class="elsevierStyleSup">22</span></a> A retrospective pharmacokinetic study involving 54 children suggested the need for 50–75<span class="elsevierStyleHsp" style=""></span>mg/kg bolus to attain a Mg level near 4<span class="elsevierStyleHsp" style=""></span>mg/dL (1.64<span class="elsevierStyleHsp" style=""></span>mmol/L).<a class="elsevierStyleCrossRef" href="#bib0095"><span class="elsevierStyleSup">19</span></a> In a study conducted in India with 47 children, Devi et al. used 100<span class="elsevierStyleHsp" style=""></span>mg/kg over 35<span class="elsevierStyleHsp" style=""></span>min with a co-administration of intravenous aminophylline. The results show an improvement in clinical and PEFR scores; the graphic display implied beneficial effects in oxygenation starting in the first few hours and continuing for 10–12<span class="elsevierStyleHsp" style=""></span>h.<a class="elsevierStyleCrossRef" href="#bib0135"><span class="elsevierStyleSup">27</span></a> Nevertheless, the co-administration of aminophylline in this study leads to doubts about whether MgSO<span class="elsevierStyleInf">4</span> alone caused this effect.</p><p id="par0080" class="elsevierStylePara elsevierViewall">The prompt initiation of therapy may be correlated with its efficacy. A study performed in Argentina indicated that early administration in the ED was associated with fewer patients, later on, requiring mechanical ventilation in a pediatric intensive care unit (PICU).<a class="elsevierStyleCrossRef" href="#bib0125"><span class="elsevierStyleSup">25</span></a> Of note, the control group comprised younger subjects and may have included infants with bronchiolitis. A large randomized clinical trial with 100 patients in India, using a modified asthma clinical severity score, demonstrated the superiority of an early intravenous MgSO<span class="elsevierStyleInf">4</span> bolus over terbutaline or aminophylline infusions<a class="elsevierStyleCrossRef" href="#bib0100"><span class="elsevierStyleSup">20</span></a>; of note, many of these patients were very young and infection-mediated asthma was not identified. Another randomized trial in a Brazilian ED demonstrated the superiority of intravenous MgSO<span class="elsevierStyleInf">4</span> over placebo, with almost identical effects to intravenous Salbutamol while using surrogate variables of efficacy in patients that were later hospitalized.<a class="elsevierStyleCrossRef" href="#bib0040"><span class="elsevierStyleSup">8</span></a> An earlier meta-analysis conducted by Cheuk et al. including five trials that assessed MgSO<span class="elsevierStyleInf">4</span><span class="elsevierStyleItalic">versus</span> placebo demonstrated MgSO<span class="elsevierStyleInf">4</span> effectiveness in preventing hospitalization.<a class="elsevierStyleCrossRef" href="#bib0140"><span class="elsevierStyleSup">28</span></a> A more recent and stricter meta-analysis involving three trials (115 children) concluded that the true estimated reduction in admission was between 86% and 26%, due to the wide confidence interval (odd ratio: 0.32, 95% CI: 0.14–0.74). Nevertheless, an number needed to treat (NNT) of 5 could be ascribed to the use of intravenous MgSO<span class="elsevierStyleInf">4</span> in the ED to prevent one hospital admission.<a class="elsevierStyleCrossRef" href="#bib0145"><span class="elsevierStyleSup">29</span></a></p><p id="par0085" class="elsevierStylePara elsevierViewall">The need to return to the ED after discharge has not been well documented. One study with 47 children reports a reduced length of stay of 5.3<span class="elsevierStyleHsp" style=""></span>h on patients who were admitted.<a class="elsevierStyleCrossRef" href="#bib0140"><span class="elsevierStyleSup">28</span></a> This is an elusive variable as, once the patient is admitted, discharge may not be solely dependent on the patient's condition but rather on the availability of medical personnel, time of the day, and day of the week.</p></span><span id="sec0040" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0100">High-dose MgSO<span class="elsevierStyleInf">4</span> continuous infusion (HDMI)</span><p id="par0090" class="elsevierStylePara elsevierViewall">Much of the magnesium in serum is attached to albumin, while ionized Mg (IoMg; the free form) is the pharmacologically active form in asthma. IoMg makes up 55% of extracellular Mg; however, the relation of Mg/IoMg is adversely altered in asthma and critically ill patients.<a class="elsevierStyleCrossRefs" href="#bib0120"><span class="elsevierStyleSup">24,25,27</span></a> Animal studies indicate that IoMg concentrations ≥1<span class="elsevierStyleHsp" style=""></span>mmol/L are required to produce smooth muscle relaxation.<a class="elsevierStyleCrossRef" href="#bib0075"><span class="elsevierStyleSup">15</span></a></p><p id="par0095" class="elsevierStylePara elsevierViewall">These and other factors lead the authors to study high-dose MgSO<span class="elsevierStyleInf">4</span> continuous infusion (HDMI) in children in the setting of severe asthma and <span class="elsevierStyleItalic">status asthmaticus</span>. HDMI has been used in patients with pulmonary hypertension, brain injury, and subarachnoid hemorrhage, as well as extensively in preeclampsia.<a class="elsevierStyleCrossRefs" href="#bib0150"><span class="elsevierStyleSup">30–33</span></a> In these scenarios, the strategy is to maintain a consistent therapeutic level to compensate for MgSO<span class="elsevierStyleInf">4</span>'s rapid elimination. This approach has been rarely adopted in asthma cases.<a class="elsevierStyleCrossRefs" href="#bib0140"><span class="elsevierStyleSup">28,34</span></a> The obstetrics and gynecology literature targets Mg infusion to clinical signs of weakening, but not losing, patellar reflexes as reflection of adequate spasmolysis. This usually represents serum Mg of 4.8–8.4<span class="elsevierStyleHsp" style=""></span>mg/dL with IoMg 0.9–1.6<span class="elsevierStyleHsp" style=""></span>mmol/L.<a class="elsevierStyleCrossRefs" href="#bib0075"><span class="elsevierStyleSup">15,35,36</span></a></p><p id="par0100" class="elsevierStylePara elsevierViewall">A retrospective study by Glover et al. on continuous intravenous MgSO<span class="elsevierStyleInf">4</span> use in children attempted to assess safety, but had many confounding variables. Those authors described a heterogeneous group with a large variation in dosage and regimen duration, bolus of 35.3<span class="elsevierStyleHsp" style=""></span>±<span class="elsevierStyleHsp" style=""></span>12.7<span class="elsevierStyleHsp" style=""></span>mg/kg, infusion of 21.6<span class="elsevierStyleHsp" style=""></span>±<span class="elsevierStyleHsp" style=""></span>6<span class="elsevierStyleHsp" style=""></span>mg/kg/h for 93.8<span class="elsevierStyleHsp" style=""></span>h<span class="elsevierStyleHsp" style=""></span>±<span class="elsevierStyleHsp" style=""></span>89.2<span class="elsevierStyleHsp" style=""></span>h, without significant side effects.<a class="elsevierStyleCrossRef" href="#bib0130"><span class="elsevierStyleSup">26</span></a></p><p id="par0105" class="elsevierStylePara elsevierViewall">In this practice, the present authors retrospectively analyzed the use of HDMI in the setting of <span class="elsevierStyleItalic">status asthmaticus</span> within the confines of the pediatric intensive care unit (PICU).<a class="elsevierStyleCrossRef" href="#bib0185"><span class="elsevierStyleSup">37</span></a> The HDMI regimens consisted of an initial bolus that was weight-dependent: 50<span class="elsevierStyleHsp" style=""></span>mg/kg (>30<span class="elsevierStyleHsp" style=""></span>kg) or 75<span class="elsevierStyleHsp" style=""></span>mg/kg (≤30<span class="elsevierStyleHsp" style=""></span>kg) over a period of 30–45<span class="elsevierStyleHsp" style=""></span>min; followed by a continuous infusion of 50<span class="elsevierStyleHsp" style=""></span>mg/kg/h, for 4<span class="elsevierStyleHsp" style=""></span>h. Serum magnesium levels were 4.4<span class="elsevierStyleHsp" style=""></span>±<span class="elsevierStyleHsp" style=""></span>0.8<span class="elsevierStyleHsp" style=""></span>mg/dL, and IoMg 0.95<span class="elsevierStyleHsp" style=""></span>±<span class="elsevierStyleHsp" style=""></span>0.2<span class="elsevierStyleHsp" style=""></span>mmol/L at the end of the infusion, within the target range. In 12 patients, troponin levels and electrocardiograms were all normal.<a class="elsevierStyleCrossRef" href="#bib0185"><span class="elsevierStyleSup">37</span></a></p><p id="par0110" class="elsevierStylePara elsevierViewall">In a following prospective study, the authors determined the HDMI pharmacokinetics VD of 0.4<span class="elsevierStyleHsp" style=""></span>±<span class="elsevierStyleHsp" style=""></span>0.13<span class="elsevierStyleHsp" style=""></span>L/kg, clearance of 1.58<span class="elsevierStyleHsp" style=""></span>±<span class="elsevierStyleHsp" style=""></span>0.24<span class="elsevierStyleHsp" style=""></span>mL/kg/min, and safety, documented levels of IoMg associated with smooth muscle relaxation and the absence of significant side effects.<a class="elsevierStyleCrossRef" href="#bib0190"><span class="elsevierStyleSup">38</span></a> This regimen was pharmacologically precise, but complex, and lead to errors in administration. After trying several regimens, a simplified regimen of 50<span class="elsevierStyleHsp" style=""></span>mg/kg/h for 4<span class="elsevierStyleHsp" style=""></span>h was adopted. In a subsequent study, the authors compared the initial and the simplified regimen, demonstrating similar serum levels.<a class="elsevierStyleCrossRef" href="#bib0195"><span class="elsevierStyleSup">39</span></a></p></span><span id="sec0045" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0105">MgSO<span class="elsevierStyleInf">4</span> HDMI <span class="elsevierStyleItalic">vs.</span> Bolus</span><p id="par0115" class="elsevierStylePara elsevierViewall">In a prospective, randomized ED study for severe asthma, with patients without underlying co-morbidity or infectious etiology, the authors determined that HDMI was superior to MgSO<span class="elsevierStyleInf">4</span> bolus (<a class="elsevierStyleCrossRef" href="#fig0005">Fig. 1</a>) in shortening the ED length of stay while reducing costs.<a class="elsevierStyleCrossRef" href="#bib0200"><span class="elsevierStyleSup">40</span></a></p><elsevierMultimedia ident="fig0005"></elsevierMultimedia><p id="par0120" class="elsevierStylePara elsevierViewall">Patients were randomized to receive intravenous MgSO<span class="elsevierStyleInf">4</span> 50<span class="elsevierStyleHsp" style=""></span>mg/kg bolus (over 1<span class="elsevierStyleHsp" style=""></span>h) or HDMI (50/mg/kg/h for 4<span class="elsevierStyleHsp" style=""></span>h), diluted in 0.9% saline solution at a concentration of 10<span class="elsevierStyleHsp" style=""></span>mg/mL. The HDMI group presented a lower length of stay (HDMI, 34<span class="elsevierStyleHsp" style=""></span>±<span class="elsevierStyleHsp" style=""></span>19<span class="elsevierStyleHsp" style=""></span>h; bolus, 48<span class="elsevierStyleHsp" style=""></span>±<span class="elsevierStyleHsp" style=""></span>19<span class="elsevierStyleHsp" style=""></span>h; <span class="elsevierStyleItalic">p</span><span class="elsevierStyleHsp" style=""></span>=<span class="elsevierStyleHsp" style=""></span>0.031; 95% CI: 1.3–26.5). Moreover, at 24<span class="elsevierStyleHsp" style=""></span>h, nine out of 19 patients (47%) in the HDMI group were discharged, <span class="elsevierStyleItalic">versus</span> two out of 21 (10%) in the bolus group (<span class="elsevierStyleItalic">p</span><span class="elsevierStyleHsp" style=""></span>=<span class="elsevierStyleHsp" style=""></span>0.012), with an absolute risk reduction (ARR) 37% (95% CI: 11–63). HDMI was superior to a bolus as an early adjunctive treatment, with a NNT of 3 (95% CI: 1.6–9.5) to facilitate a discharge at 24<span class="elsevierStyleHsp" style=""></span>h from the ED.<a class="elsevierStyleCrossRef" href="#bib0195"><span class="elsevierStyleSup">39</span></a> Interim analysis at 12 and 36<span class="elsevierStyleHsp" style=""></span>h presented the same trends favoring the HDMI group; two-thirds of the patients in this group were discharged at 36<span class="elsevierStyleHsp" style=""></span>h (<span class="elsevierStyleItalic">p</span><span class="elsevierStyleHsp" style=""></span>=<span class="elsevierStyleHsp" style=""></span>0.009; ARR: 42%; 95% CI: 14–70%; NNT: 3; 95% CI: 1.4–7.3). The use of HDMI in the ED management of asthma was cost-effective in the present institution.<a class="elsevierStyleCrossRef" href="#bib0195"><span class="elsevierStyleSup">39</span></a></p></span><span id="sec0050" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0110">Side effects and potential challenges</span><p id="par0125" class="elsevierStylePara elsevierViewall">MgSO<span class="elsevierStyleInf">4</span>-induced muscle weakness, with the consequent risk of respiratory failure, and potential vasodilatation, with subsequent hypotension, are of concerns when utilized in the context of asthma.<a class="elsevierStyleCrossRefs" href="#bib0205"><span class="elsevierStyleSup">41,42</span></a> Although many earlier studies showed minimal or no adverse effects, the fear of these side effects is pervasive. Minor side effects were described in 16% of patients: epigastric warmth, tingling, numbness, and pain at the site of infusion, all of them appearing within 5<span class="elsevierStyleHsp" style=""></span>min of the initiation and disappearing shortly afterwards.<a class="elsevierStyleCrossRef" href="#bib0135"><span class="elsevierStyleSup">27</span></a> Of note, that study appears to have used a bolus of 100<span class="elsevierStyleHsp" style=""></span>mg/kg over 35<span class="elsevierStyleHsp" style=""></span>min.<a class="elsevierStyleCrossRef" href="#bib0135"><span class="elsevierStyleSup">27</span></a> Schuh et al. found contradictory behavior in an online survey of ED physicians. While more than 80% of responders agreed that there were data to support use of MgSO<span class="elsevierStyleInf">4</span>, it was utilized in less than 20% of the time; 24% of surveyed physicians recalled observing at least one episode of hypotension requiring intervention, and 23% had concerns about its side effects. An online survey, a methodology that suffers from self-selection bias and subjective recall bias, emphasized the general predisposition of physicians to develop opinions when there is lack of data.<a class="elsevierStyleCrossRef" href="#bib0170"><span class="elsevierStyleSup">34</span></a></p><p id="par0130" class="elsevierStylePara elsevierViewall">In four HDMI studies, no significant side effects were observed, except for one patient reporting nausea, two pain at the injection site, and two generalized flushing. No patient experienced significant muscle weakness or the need for respiratory support. Low diastolic blood pressure should be expected during HDMI if measured by automated sphygmomanometer. The authors observed normal troponin levels of 0.05<span class="elsevierStyleHsp" style=""></span>±<span class="elsevierStyleHsp" style=""></span>0.01<span class="elsevierStyleHsp" style=""></span>ng/mL and no EKG changes during HDMI.<a class="elsevierStyleCrossRef" href="#bib0190"><span class="elsevierStyleSup">38</span></a> Of note, in a non-invasive method, the changes in tonality between the 4th to the 5th Korotkoff determine the diastolic blood pressure.<a class="elsevierStyleCrossRef" href="#bib0215"><span class="elsevierStyleSup">43</span></a> Automated sphygmomanometers have difficult elucidating this change when patients are receiving a high dose β<span class="elsevierStyleInf">2</span> adrenergic or HDMI. A study with invasive intra-arterial line may be able to refine this point.</p><p id="par0135" class="elsevierStylePara elsevierViewall">A contemporary problem is that an increased proportion of patients with asthma are obese,<a class="elsevierStyleCrossRefs" href="#bib0220"><span class="elsevierStyleSup">44,45</span></a> which requires adjustments in the intravenous dose. In this practice, the authors adjust the dosage to ideal body weight when BMI is ≥ 25. Further studies in this area are also needed.</p></span><span id="sec0055" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0115">Inhaled MgSO<span class="elsevierStyleInf">4</span> in asthma</span><p id="par0140" class="elsevierStylePara elsevierViewall">The large efficacy of the nebulized β-agonists in the treatment of asthma makes their role undisputed. However, inhaled medications are difficult to deliver to the affected bronchi, even under ideal conditions. Studies have shown that only about 10% of bronchodilators reach the lung and are largely affected by respiratory rate, tidal volumes, dead space ventilation (Vd/Vt), bronchoconstriction, method of delivery, mouth breathing, and particle size and deposition.</p><p id="par0145" class="elsevierStylePara elsevierViewall">The use of inhaled magnesium sulfate has presented inconsistent results. A systematic review showed that clinical trials that assessed the use of inhaled MgSO4 failed to find a beneficial effect, and its use is not widely recommended.<a class="elsevierStyleCrossRef" href="#bib0230"><span class="elsevierStyleSup">46</span></a></p></span></span><span id="sec0060" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0120">Conclusions</span><p id="par0150" class="elsevierStylePara elsevierViewall">Improvements in the ED management of severe asthma, a leading diagnosis for admission to hospitals, could have a significant economic impact, in particular in areas with lower socioeconomic resources. A preplanned, organized, and decisive ED initial management is paramount to reverse a condition that can evolve toward respiratory failure. The authors emphasize the role of MgSO<span class="elsevierStyleInf">4</span> as an adjunctive therapy in the initial management of asthma, while β<span class="elsevierStyleInf">2</span> adrenergic and corticosteroids remain the primary therapy. It is possible that the inconsistent results from previous MgSO<span class="elsevierStyleInf">4</span> studies were due to a failure to achieve sustained serum magnesium and spasmolytic effects for β<span class="elsevierStyleInf">2</span> adrenergic to reach the site of action. Incorporating HDMI at 50<span class="elsevierStyleHsp" style=""></span>mg/kg/h for 4<span class="elsevierStyleHsp" style=""></span>h in the ED facilitates early discharge, reduces hospitalization rates, and is cost-effective.</p></span><span id="sec0065" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0125">Conflicts of interest</span><p id="par0155" class="elsevierStylePara elsevierViewall">The authors declare no conflicts of interest.</p></span></span>" "textoCompletoSecciones" => array:1 [ "secciones" => array:8 [ 0 => array:3 [ "identificador" => "xres938135" "titulo" => "Abstract" "secciones" => array:4 [ 0 => array:2 [ "identificador" => "abst0005" "titulo" => "Objectives" ] 1 => array:2 [ "identificador" => "abst0010" "titulo" => "Source" ] 2 => array:2 [ "identificador" => "abst0015" "titulo" => "Summary of the data" ] 3 => array:2 [ "identificador" => "abst0020" "titulo" => "Conclusions" ] ] ] 1 => array:2 [ "identificador" => "xpalclavsec911884" "titulo" => "Keywords" ] 2 => array:3 [ "identificador" => "xres938136" "titulo" => "Resumo" "secciones" => array:4 [ 0 => array:2 [ "identificador" => "abst0025" "titulo" => "Objetivos" ] 1 => array:2 [ "identificador" => "abst0030" "titulo" => "Fonte" ] 2 => array:2 [ "identificador" => "abst0035" "titulo" => "Resumo dos dados" ] 3 => array:2 [ "identificador" => "abst0040" "titulo" => "Conclusões" ] ] ] 3 => array:2 [ "identificador" => "xpalclavsec911886" "titulo" => "Palavras-chave" ] 4 => array:3 [ "identificador" => "sec0005" "titulo" => "Introduction" "secciones" => array:10 [ 0 => array:2 [ "identificador" => "sec0010" "titulo" => "Perspective on a health challenge" ] 1 => array:2 [ "identificador" => "sec0015" "titulo" => "Pathophysiology" ] 2 => array:2 [ "identificador" => "sec0020" "titulo" => "Clinical presentation" ] 3 => array:2 [ "identificador" => "sec0025" "titulo" => "Initial ED management" ] 4 => array:2 [ "identificador" => "sec0030" "titulo" => "MgSO mechanism of action and kinetics" ] 5 => array:2 [ "identificador" => "sec0035" "titulo" => "Experience in the use of intravenous MgSO in asthmatic children" ] 6 => array:2 [ "identificador" => "sec0040" "titulo" => "High-dose MgSO continuous infusion (HDMI)" ] 7 => array:2 [ "identificador" => "sec0045" "titulo" => "MgSO HDMI vs. Bolus" ] 8 => array:2 [ "identificador" => "sec0050" "titulo" => "Side effects and potential challenges" ] 9 => array:2 [ "identificador" => "sec0055" "titulo" => "Inhaled MgSO in asthma" ] ] ] 5 => array:2 [ "identificador" => "sec0060" "titulo" => "Conclusions" ] 6 => array:2 [ "identificador" => "sec0065" "titulo" => "Conflicts of interest" ] 7 => array:1 [ "titulo" => "References" ] ] ] "pdfFichero" => "main.pdf" "tienePdf" => true "fechaRecibido" => "2017-05-02" "fechaAceptado" => "2017-05-26" "PalabrasClave" => array:2 [ "en" => array:1 [ 0 => array:4 [ "clase" => "keyword" "titulo" => "Keywords" "identificador" => "xpalclavsec911884" "palabras" => array:6 [ 0 => "Magnesium sulfate" 1 => "High dose infusion" 2 => "Severe asthma" 3 => "Pediatric" 4 => "Emergency department" 5 => "Cost-effective" ] ] ] "pt" => array:1 [ 0 => array:4 [ "clase" => "keyword" "titulo" => "Palavras-chave" "identificador" => "xpalclavsec911886" "palabras" => array:6 [ 0 => "Sulfato de magnésio" 1 => "Alta dose de infusão" 2 => "Asma grave" 3 => "Pediátrico" 4 => "Serviço de emergência" 5 => "Custo-benefício" ] ] ] ] "tieneResumen" => true "resumen" => array:2 [ "en" => array:3 [ "titulo" => "Abstract" "resumen" => "<span id="abst0005" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0010">Objectives</span><p id="spar0005" class="elsevierStyleSimplePara elsevierViewall">To describe the role of intravenous magnesium sulfate (MgSO<span class="elsevierStyleInf">4</span>) as therapy for acute severe asthma in the pediatric emergency department (ED).</p></span> <span id="abst0010" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0015">Source</span><p id="spar0010" class="elsevierStyleSimplePara elsevierViewall">Publications were searched in the PubMed and Cochrane databases using the following keywords: magnesium AND asthma AND children AND clinical trial. A total of 53 publications were retrieved using this criteria. References of relevant articles were also screened. The authors included the summary of relevant publications where intravenous magnesium sulfate was studied in children (age <18 years) with acute asthma. The NAEPP and Global Initiative for Asthma expert panel guidelines were also reviewed.</p></span> <span id="abst0015" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0020">Summary of the data</span><p id="spar0015" class="elsevierStyleSimplePara elsevierViewall">There is a large variability in the ED practices on the intravenous administration of MgSO<span class="elsevierStyleInf">4</span> for severe asthma. The pharmacokinetics of MgSO<span class="elsevierStyleInf">4</span> is often not taken into account with a consequent impact in its pharmacodynamics properties. The cumulative evidence points to the effectiveness of intravenous MgSO<span class="elsevierStyleInf">4</span> in preventing hospitalization, if utilized in a timely manner and at an appropriate dosage (50–75<span class="elsevierStyleHsp" style=""></span>mg/kg). For every five children treated in the ED, one hospital admission could be prevented. Another administration modality is a high-dose continuous magnesium sulfate infusion (HDMI) as 50<span class="elsevierStyleHsp" style=""></span>mg/kg/h/4<span class="elsevierStyleHsp" style=""></span>h (200<span class="elsevierStyleHsp" style=""></span>mg/kg/4<span class="elsevierStyleHsp" style=""></span>h). The early utilization of HDMI for non-infectious mediated asthma may be superior to a MgSO<span class="elsevierStyleInf">4</span> bolus in avoiding admissions and expediting discharges from the ED. HDMI appears to be cost-effective if applied early to a selected population. Intravenous MgSO<span class="elsevierStyleInf">4</span> has a similar safety profile than other asthma therapies.</p></span> <span id="abst0020" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0025">Conclusions</span><p id="spar0020" class="elsevierStyleSimplePara elsevierViewall">Treatment with intravenous MgSO<span class="elsevierStyleInf">4</span> reduces the odds of hospital admissions. The use of intravenous MgSO<span class="elsevierStyleInf">4</span> in the emergency room was not associated with significant side effects or harm. The authors emphasize the role of MgSO<span class="elsevierStyleInf">4</span> as an adjunctive therapy, while corticosteroids and beta agonist remain the primary acute therapeutic agents.</p></span>" "secciones" => array:4 [ 0 => array:2 [ "identificador" => "abst0005" "titulo" => "Objectives" ] 1 => array:2 [ "identificador" => "abst0010" "titulo" => "Source" ] 2 => array:2 [ "identificador" => "abst0015" "titulo" => "Summary of the data" ] 3 => array:2 [ "identificador" => "abst0020" "titulo" => "Conclusions" ] ] ] "pt" => array:3 [ "titulo" => "Resumo" "resumen" => "<span id="abst0025" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0035">Objetivos</span><p id="spar0025" class="elsevierStyleSimplePara elsevierViewall">Descrever o papel do sulfato de magnésio intravenoso (MgSO<span class="elsevierStyleInf">4</span>) como terapia para asma grave aguda no serviço de emergência pediátrica (SE).</p></span> <span id="abst0030" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0040">Fonte</span><p id="spar0030" class="elsevierStyleSimplePara elsevierViewall">As publicações foram pesquisadas no banco de dados PubMed e Cochrane utilizando as seguintes palavras-chave: magnésio E asma E crianças E ensaio clínico. Foi encontrado um total de 53 publicações utilizando esses critérios. As referências de artigos relevantes também foram examinadas. Incluímos o resumo de publicações relevantes quando o sulfato de magnésio intravenoso foi estudado em crianças (idade<span class="elsevierStyleHsp" style=""></span><<span class="elsevierStyleHsp" style=""></span>18 anos) com asma aguda. Revisamos também as diretrizes do Programa Nacional para a Educação e Prevenção da Asma (NAEPP) e do painel de especialistas da Iniciativa Global para Asma.</p></span> <span id="abst0035" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0045">Resumo dos dados</span><p id="spar0035" class="elsevierStyleSimplePara elsevierViewall">Há uma grande variabilidade nas práticas do SE na administração intravenosa do MgSO<span class="elsevierStyleInf">4</span> para asma grave. A farmacocinética do MgSO<span class="elsevierStyleInf">4</span> normalmente não leva em conta um impacto posterior em suas propriedades farmacodinâmicas. A comprovação cumulativa aponta para a eficácia do MgSO<span class="elsevierStyleInf">4</span> intravenoso na prevenção da internação, se utilizado quando necessário e em uma dosagem adequada (50-75<span class="elsevierStyleHsp" style=""></span>mg/kg). Uma internação hospitalar pode ser evitada para cada cinco crianças tratadas no SE. Outra modalidade de administração é a infusão prolongada de alta dose de sulfato de magnésio (HDMI) a 50<span class="elsevierStyleHsp" style=""></span>mg/kg/hora/4 horas (200<span class="elsevierStyleHsp" style=""></span>mg/kg/4 horas). O uso precoce da HDMI, para asma não infecciosa mediada, pode ser superior a um MgSO<span class="elsevierStyleInf">4</span> em bolus para evitar internações e antecipar as altas do SE. A HDMI parece ter bom custo-benefício se aplicada precocemente em uma população selecionada. O MgSO4 intravenoso possui um perfil de segurança semelhante a outras terapias de asma.</p></span> <span id="abst0040" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0050">Conclusões</span><p id="spar0040" class="elsevierStyleSimplePara elsevierViewall">O tratamento com MgSO<span class="elsevierStyleInf">4</span> intravenoso reduz as chances de internações hospitalares. O uso de MgSO<span class="elsevierStyleInf">4</span> intravenoso no pronto socorro não é associado a efeitos colaterais ou danos significativos. Enfatizamos o papel do MgSO<span class="elsevierStyleInf">4</span> como uma terapia adjuvante, ao passo que os corticosteroides e as beta-agonistas continuam os agentes terapêuticos agudos primários.</p></span>" "secciones" => array:4 [ 0 => array:2 [ "identificador" => "abst0025" "titulo" => "Objetivos" ] 1 => array:2 [ "identificador" => "abst0030" "titulo" => "Fonte" ] 2 => array:2 [ "identificador" => "abst0035" "titulo" => "Resumo dos dados" ] 3 => array:2 [ "identificador" => "abst0040" "titulo" => "Conclusões" ] ] ] ] "NotaPie" => array:1 [ 0 => array:2 [ "etiqueta" => "☆" "nota" => "<p class="elsevierStyleNotepara" id="npar0005">Please cite this article as: Irazuzta JE, Chiriboga N. Magnesium sulfate infusion for acute asthma in the emergency department. J Pediatr (Rio J). 2017;93:19–25.</p>" ] ] "multimedia" => array:1 [ 0 => array:7 [ "identificador" => "fig0005" "etiqueta" => "Figure 1" "tipo" => "MULTIMEDIAFIGURA" "mostrarFloat" => true "mostrarDisplay" => false "figura" => array:1 [ 0 => array:4 [ "imagen" => "gr1.jpeg" "Alto" => 1022 "Ancho" => 1342 "Tamanyo" => 49989 ] ] "descripcion" => array:1 [ "en" => "<p id="spar0045" class="elsevierStyleSimplePara elsevierViewall">Percentage of patients discharged home from the ED by group. Bolus, 50<span class="elsevierStyleHsp" style=""></span>mg/kg/1<span class="elsevierStyleHsp" style=""></span>h; HDMI, 200<span class="elsevierStyleHsp" style=""></span>mg/kg/4<span class="elsevierStyleHsp" style=""></span>h. Columns represent patients discharged, by group. HDMI, high-dose magnesium infusion.</p>" ] ] ] "bibliografia" => array:2 [ "titulo" => "References" "seccion" => array:1 [ 0 => array:2 [ "identificador" => "bibs0005" "bibliografiaReferencia" => array:46 [ 0 => array:3 [ "identificador" => "bib0005" "etiqueta" => "1" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "The new National Asthma Education and Prevention Program's guidelines on the diagnosis and management of asthma and childhood asthma treatment" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:1 [ 0 => "H.W. Kelly" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:5 [ "tituloSerie" => "J Allergy Clin Immunol" "fecha" => "2008" "volumen" => "20" "paginaInicial" => "263" "paginaFinal" => "268" ] ] ] ] ] ] 1 => array:3 [ "identificador" => "bib0010" "etiqueta" => "2" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Prevalence of asthma and allergic diseases in adolescents: nine year follow up study (2003–2012)" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "D. Solé" 1 => "N.A. Rosário Filho" 2 => "E.S. Sarinho" 3 => "I.C. Camelo-Nunes" 4 => "B.A. Barreto" 5 => "M.L. Medeiros" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:5 [ "tituloSerie" => "J Pediatr" "fecha" => "2015" "volumen" => "91" "paginaInicial" => "30" "paginaFinal" => "35" ] ] ] ] ] ] 2 => array:3 [ "identificador" => "bib0015" "etiqueta" => "3" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Asthma mortality among Brazilian children up to 19 years old between 1980 and 2007" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:5 [ 0 => "S.O. Prietsch" 1 => "L. Zhang" 2 => "A.R. Catharino" 3 => "L. Vauchinski" 4 => "F.E. Rodrigues" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:5 [ "tituloSerie" => "J Pediatr" "fecha" => "2012" "volumen" => "88" "paginaInicial" => "384" "paginaFinal" => "388" ] ] ] ] ] ] 3 => array:3 [ "identificador" => "bib0020" "etiqueta" => "4" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Critical care for pediatric asthma: wide care variability and challenges for study" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "S.L. Bratton" 1 => "C.J. Newth" 2 => "A.F. Zuppa" 3 => "F.W. Moler" 4 => "K.L. Meert" 5 => "R.A. Berg" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1097/PCC.0b013e318238b428" "Revista" => array:6 [ "tituloSerie" => "Pediatr Crit Care Med" "fecha" => "2012" "volumen" => "13" "paginaInicial" => "407" "paginaFinal" => "414" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/22067984" "web" => "Medline" ] ] ] ] ] ] ] ] 4 => array:3 [ "identificador" => "bib0025" "etiqueta" => "5" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Overview of the innervation of the lung" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:1 [ 0 => "M. Belvisi" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:6 [ "tituloSerie" => "Curr Opin Pharmacol" "fecha" => "2002" "volumen" => "2" "paginaInicial" => "211" "paginaFinal" => "215" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/12020459" "web" => "Medline" ] ] ] ] ] ] ] ] 5 => array:3 [ "identificador" => "bib0030" "etiqueta" => "6" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "The pulmonary index score as a clinical assessment tool for acute childhood asthma" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:3 [ 0 => "P. Hsu" 1 => "L.T. Lam" 2 => "G. Browne" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1016/j.anai.2010.10.009" "Revista" => array:6 [ "tituloSerie" => "Ann Allergy Asthma Immunol" "fecha" => "2010" "volumen" => "105" "paginaInicial" => "425" "paginaFinal" => "429" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/21130379" "web" => "Medline" ] ] ] ] ] ] ] ] 6 => array:3 [ "identificador" => "bib0035" "etiqueta" => "7" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "FEV1 performance among patients with acute asthma: results from a multicenter clinical trial" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:4 [ 0 => "R.A. Silverman" 1 => "E. Flaster" 2 => "P.L. Enright" 3 => "S.G. Simonson" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1378/chest.06-0530" "Revista" => array:6 [ "tituloSerie" => "Chest" "fecha" => "2007" "volumen" => "131" "paginaInicial" => "164" "paginaFinal" => "171" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/17218571" "web" => "Medline" ] ] ] ] ] ] ] ] 7 => array:3 [ "identificador" => "bib0040" "etiqueta" => "8" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Controlled study on intravenous magnesium sulfate or salbutamol in early treatment of severe acute asthma attack in children" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:4 [ 0 => "J.C. Santana" 1 => "S.S. Barreto" 2 => "J.P. Piva" 3 => "P.C. Garcia" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:5 [ "tituloSerie" => "J Pediatr" "fecha" => "2001" "volumen" => "77" "paginaInicial" => "279" "paginaFinal" => "287" ] ] ] ] ] ] 8 => array:3 [ "identificador" => "bib0045" "etiqueta" => "9" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Helium/oxygen-driven albuterol nebulization in the management of children with <span class="elsevierStyleItalic">status asthmaticus</span>: a randomized, placebo-controlled trial" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:1 [ 0 => "M. Bigham" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:6 [ "tituloSerie" => "Pediatr Crit Care Med" "fecha" => "2010" "volumen" => "11" "paginaInicial" => "356" "paginaFinal" => "361" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/20464778" "web" => "Medline" ] ] ] ] ] ] ] ] 9 => array:3 [ "identificador" => "bib0050" "etiqueta" => "10" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Use of helium-oxygen mixture (Heliox<span class="elsevierStyleSup">®</span>) in the treatment of obstructive lower airway disease in a pediatric emergency department" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:1 [ 0 => "L.R. Braun Filho" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:5 [ "tituloSerie" => "J Pediatr" "fecha" => "2010" "volumen" => "86" "paginaInicial" => "424" "paginaFinal" => "428" ] ] ] ] ] ] 10 => array:3 [ "identificador" => "bib0055" "etiqueta" => "11" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Safety, efficacy, and tolerability of early initiation of noninvasive positive pressure ventilation in pediatric patients admitted with <span class="elsevierStyleItalic">status asthmaticus</span>" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:6 [ 0 => "S. Basnet" 1 => "G. Mander" 2 => "J. Andoh" 3 => "H. Klaska" 4 => "S. Verhulst" 5 => "J. Koirala" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:5 [ "tituloSerie" => "Ped Crit Care Med" "fecha" => "2012" "volumen" => "13" "paginaInicial" => "393" "paginaFinal" => "398" ] ] ] ] ] ] 11 => array:3 [ "identificador" => "bib0060" "etiqueta" => "12" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Non-invasive positive pressure ventilation for acute asthma in children" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:4 [ 0 => "S.K. Korang" 1 => "J. Feinberg" 2 => "J. Wetterslev" 3 => "J.C. Jakobsen" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1002/14651858.CD012067.pub2" "Revista" => array:5 [ "tituloSerie" => "Cochrane Database Syst Rev" "fecha" => "2016" "volumen" => "9" "paginaInicial" => "CD012067" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/27687114" "web" => "Medline" ] ] ] ] ] ] ] ] 12 => array:3 [ "identificador" => "bib0065" "etiqueta" => "13" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "The nature of the neuromuscular block produced by magnesium" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:2 [ 0 => "J. Del Castillo" 1 => "L. Engbaek" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:6 [ "tituloSerie" => "J Physiol" "fecha" => "1954" "volumen" => "124" "paginaInicial" => "370" "paginaFinal" => "384" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/13175138" "web" => "Medline" ] ] ] ] ] ] ] ] 13 => array:3 [ "identificador" => "bib0070" "etiqueta" => "14" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Magnesium as a relaxing factor of airway smooth muscles" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:3 [ 0 => "K.I. Gourgoulianis" 1 => "G. Chatziparasidis" 2 => "A. Chatziefthimiou" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1089/089426801316970259" "Revista" => array:6 [ "tituloSerie" => "J Aerosol Med" "fecha" => "2004" "volumen" => "14" "paginaInicial" => "301" "paginaFinal" => "307" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/11693841" "web" => "Medline" ] ] ] ] ] ] ] ] 14 => array:3 [ "identificador" => "bib0075" "etiqueta" => "15" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Spasmolytic effect of magnesium sulfate on serotonin-induced pulmonary hypertension and bronchoconstriction in dogs" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:6 [ 0 => "H. Yoshioka" 1 => "K. Hirota" 2 => "T. Sato" 3 => "Y. Hashimoto" 4 => "H. Ishihara" 5 => "A. Matsuki" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:6 [ "tituloSerie" => "Acta Anaesthesiol Scand" "fecha" => "2001" "volumen" => "45" "paginaInicial" => "435" "paginaFinal" => "440" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/11300381" "web" => "Medline" ] ] ] ] ] ] ] ] 15 => array:3 [ "identificador" => "bib0080" "etiqueta" => "16" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Magnesium attenuates the neutrophil respiratory burst in adult asthmatic patients" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:2 [ 0 => "C.B. Cairns" 1 => "M. Krafi" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:6 [ "tituloSerie" => "Acad Emerg Med" "fecha" => "1996" "volumen" => "3" "paginaInicial" => "1093" "paginaFinal" => "1097" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/8959161" "web" => "Medline" ] ] ] ] ] ] ] ] 16 => array:3 [ "identificador" => "bib0085" "etiqueta" => "17" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Antiasthmatic drug therapy and calcium ions: review of pathogenesis and role of calcium" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:1 [ 0 => "E. Middleton" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:4 [ "tituloSerie" => "J Pharm Sci" "fecha" => "1980" "volumen" => "69" "paginaInicial" => "243251" ] ] ] ] ] ] 17 => array:3 [ "identificador" => "bib0090" "etiqueta" => "18" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Some effects of magnesium loading upon renal excretion of magnesium and certain other electrolytes" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:2 [ 0 => "L.C. Chesley" 1 => "I. Tepper" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1172/JCI103726" "Revista" => array:6 [ "tituloSerie" => "J Clin Invest" "fecha" => "1958" "volumen" => "37" "paginaInicial" => "1362" "paginaFinal" => "1372" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/13575537" "web" => "Medline" ] ] ] ] ] ] ] ] 18 => array:3 [ "identificador" => "bib0095" "etiqueta" => "19" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Clinical pharmacokinetics of magnesium sulfate in the treatment of children with severe acute asthma" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:6 [ 0 => "J.E. Rower" 1 => "X. Liu" 2 => "T. Yu" 3 => "M. Mundorff" 4 => "C.M. Sherwin" 5 => "M. Johnson" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1007/s00228-016-2165-3" "Revista" => array:6 [ "tituloSerie" => "Eur J Clin Pharmacol" "fecha" => "2017" "volumen" => "73" "paginaInicial" => "325" "paginaFinal" => "331" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/27909740" "web" => "Medline" ] ] ] ] ] ] ] ] 19 => array:3 [ "identificador" => "bib0100" "etiqueta" => "20" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Randomised comparison of intravenous magnesium sulphate, terbutaline and aminophylline for children with acute severe asthma" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:4 [ 0 => "S. Singhi" 1 => "S. Grover" 2 => "A. Bansal" 3 => "K. Chopra" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1111/apa.12780" "Revista" => array:6 [ "tituloSerie" => "Acta Paediatr" "fecha" => "2014" "volumen" => "103" "paginaInicial" => "1301" "paginaFinal" => "1306" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/25164315" "web" => "Medline" ] ] ] ] ] ] ] ] 20 => array:3 [ "identificador" => "bib0105" "etiqueta" => "21" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Which intravenous bronchodilators are being administered to children presenting with acute severe wheeze in the UK and Ireland" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:6 [ 0 => "I. Morris" 1 => "M.D. Lyttle" 2 => "R. O'Sullivan" 3 => "N. Sargant" 4 => "I.J. Doull" 5 => "C.V. Powell" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1136/thoraxjnl-2014-206041" "Revista" => array:6 [ "tituloSerie" => "Thorax" "fecha" => "2014" "volumen" => "70" "paginaInicial" => "88" "paginaFinal" => "91" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/25303945" "web" => "Medline" ] ] ] ] ] ] ] ] 21 => array:3 [ "identificador" => "bib0110" "etiqueta" => "22" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Higher-dose intravenous magnesium therapy for children with moderate to severe acute asthma" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:3 [ 0 => "L. Ciarallo" 1 => "D. Brousseau" 2 => "S. Reinert" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:6 [ "tituloSerie" => "Arch Pediatr Adolesc Med" "fecha" => "2000" "volumen" => "154" "paginaInicial" => "979" "paginaFinal" => "983" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/11030848" "web" => "Medline" ] ] ] ] ] ] ] ] 22 => array:3 [ "identificador" => "bib0115" "etiqueta" => "23" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "A randomized trial of magnesium in the emergency department treatment of children with asthma" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "R.J. Scarfone" 1 => "J.M. Loiselle" 2 => "M.D. Joffe" 3 => "C.C. Mull" 4 => "S. Stiller" 5 => "K. Thompson" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1067/mem.2000.111060" "Revista" => array:6 [ "tituloSerie" => "Ann Emerg Med" "fecha" => "2000" "volumen" => "36" "paginaInicial" => "572" "paginaFinal" => "578" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/11097697" "web" => "Medline" ] ] ] ] ] ] ] ] 23 => array:3 [ "identificador" => "bib0120" "etiqueta" => "24" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "The 3Mg trial: a randomised controlled trial of intravenous or nebulised magnesium sulphate <span class="elsevierStyleItalic">versus</span> placebo in adults with severe acute asthma" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:5 [ 0 => "S. Goodacre" 1 => "J. Cohen" 2 => "M. Braidburn" 3 => "J. Benger" 4 => "T. Coats" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.3310/hta18710" "Revista" => array:6 [ "tituloSerie" => "Health Technol Assess" "fecha" => "2014" "volumen" => "18" "paginaInicial" => "1" "paginaFinal" => "168" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/26099138" "web" => "Medline" ] ] ] ] ] ] ] ] 24 => array:3 [ "identificador" => "bib0125" "etiqueta" => "25" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Effectiveness of magnesium sulfate as initial treatment of acute severe asthma in children: a randomized, controlled trial" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:1 [ 0 => "S. Torres" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.5546/aap.2012.291" "Revista" => array:6 [ "tituloSerie" => "Arch Argent Pediatr" "fecha" => "2012" "volumen" => "110" "paginaInicial" => "291" "paginaFinal" => "297" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/22859321" "web" => "Medline" ] ] ] ] ] ] ] ] 25 => array:3 [ "identificador" => "bib0130" "etiqueta" => "26" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Magnesium sulfate administered via continuous intravenous infusion in pediatric patients with refractory wheezing" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:3 [ 0 => "M.L. Glover" 1 => "C. Machado" 2 => "B.R. Totapally" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1053/jcrc.2002.36759" "Revista" => array:6 [ "tituloSerie" => "J Crit Care" "fecha" => "2002" "volumen" => "17" "paginaInicial" => "255" "paginaFinal" => "258" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/12501154" "web" => "Medline" ] ] ] ] ] ] ] ] 26 => array:3 [ "identificador" => "bib0135" "etiqueta" => "27" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Intravenous magnesium sulfate in acute severe asthma not responding to conventional therapy" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:5 [ 0 => "P.R. Devi" 1 => "L. Kumar" 2 => "S.C. Singhi" 3 => "R. Prasad" 4 => "M. Singh" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:6 [ "tituloSerie" => "Indian Pediatr" "fecha" => "1997" "volumen" => "34" "paginaInicial" => "389" "paginaFinal" => "397" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/9332112" "web" => "Medline" ] ] ] ] ] ] ] ] 27 => array:3 [ "identificador" => "bib0140" "etiqueta" => "28" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "A meta-analysis on intravenous magnesium sulphate for treating acute asthma" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:1 [ 0 => "D.K. Cheuk" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1136/adc.2004.050005" "Revista" => array:6 [ "tituloSerie" => "Arch Dis Child" "fecha" => "2005" "volumen" => "90" "paginaInicial" => "74" "paginaFinal" => "77" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/15613519" "web" => "Medline" ] ] ] ] ] ] ] ] 28 => array:3 [ "identificador" => "bib0145" "etiqueta" => "29" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Intravenous magnesium sulfate for treating children with acute asthma in the emergency department" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:2 [ 0 => "B. Griffiths" 1 => "K.M. Kew" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1002/14651858.CD011050.pub2" "Revista" => array:5 [ "tituloSerie" => "Cochrane Database Syst Rev" "fecha" => "2016" "volumen" => "4" "paginaInicial" => "CD011050" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/27126744" "web" => "Medline" ] ] ] ] ] ] ] ] 29 => array:3 [ "identificador" => "bib0150" "etiqueta" => "30" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "A comparison of intravenous and intramuscular magnesium sulfate regimens in preeclampsia" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:3 [ 0 => "B.M. Sibai" 1 => "J. Graham" 2 => "J.H. Mccubbin" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:6 [ "tituloSerie" => "Am J Obstet Gynecol" "fecha" => "1984" "volumen" => "150" "paginaInicial" => "728" "paginaFinal" => "733" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/6496595" "web" => "Medline" ] ] ] ] ] ] ] ] 30 => array:3 [ "identificador" => "bib0155" "etiqueta" => "31" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Pilot study to determine the hemodynamic safety and feasibility of magnesium sulfate infusion in children with severe traumatic brain injury" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "J.E. Natale" 1 => "A.M. Guerguerian" 2 => "J.G. Joseph" 3 => "R. McCarter" 4 => "C. Shao" 5 => "B. Slomine" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:5 [ "tituloSerie" => "Pediat Crit Care Med" "fecha" => "2007" "volumen" => "8" "paginaInicial" => "1" "paginaFinal" => "9" ] ] ] ] ] ] 31 => array:3 [ "identificador" => "bib0160" "etiqueta" => "32" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Intravenous magnesium sulphate <span class="elsevierStyleItalic">vs</span>. inhaled nitric oxide for moderate, persistent pulmonary hypertension of the newborn: a multicentre, retrospective study" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "F. Raimondi" 1 => "F. Migliaro" 2 => "L. Capasso" 3 => "G. Ausanio" 4 => "M. Bisceglia" 5 => "P. Giliberti" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1093/tropej/fmm101" "Revista" => array:6 [ "tituloSerie" => "J Trop Pediatr" "fecha" => "2007" "volumen" => "54" "paginaInicial" => "196" "paginaFinal" => "199" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/18048460" "web" => "Medline" ] ] ] ] ] ] ] ] 32 => array:3 [ "identificador" => "bib0165" "etiqueta" => "33" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Magnesium sulphate in the management of patients with aneurysmal subarachnoid haemorrhage: a meta-analysis of prospective controlled trials" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:6 [ 0 => "L. Ma" 1 => "W. Liu" 2 => "J. Zhang" 3 => "G. Chen" 4 => "J. Fan" 5 => "H. Sheng" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.3109/02699051003610516" "Revista" => array:6 [ "tituloSerie" => "Brain Inj" "fecha" => "2010" "volumen" => "24" "paginaInicial" => "730" "paginaFinal" => "735" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/20334471" "web" => "Medline" ] ] ] ] ] ] ] ] 33 => array:3 [ "identificador" => "bib0170" "etiqueta" => "34" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "North American practice patterns of intravenous magnesium therapy in severe acute asthma in children" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "S. Schuh" 1 => "C. Macias" 2 => "S.B. Freedman" 3 => "A.C. Plint" 4 => "J.J. Zorc" 5 => "L. Bajaj" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1111/j.1553-2712.2010.00913.x" "Revista" => array:6 [ "tituloSerie" => "Acad Emerg Med" "fecha" => "2010" "volumen" => "17" "paginaInicial" => "1189" "paginaFinal" => "1196" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/21175517" "web" => "Medline" ] ] ] ] ] ] ] ] 34 => array:3 [ "identificador" => "bib0175" "etiqueta" => "35" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Ionized and total magnesium concentration in patients with severe preeclampsia-eclampsia undergoing magnesium sulfate therapy" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:3 [ 0 => "B.S. Aali" 1 => "P. Khazaeli" 2 => "F. Ghasemi" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1111/j.1447-0756.2007.00508.x" "Revista" => array:6 [ "tituloSerie" => "J Obstet Gynaecol Res" "fecha" => "2007" "volumen" => "33" "paginaInicial" => "138" "paginaFinal" => "143" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/17441885" "web" => "Medline" ] ] ] ] ] ] ] ] 35 => array:3 [ "identificador" => "bib0180" "etiqueta" => "36" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Serum ionized magnesium levels during intravenous MGSO4 therapy of preeclamptic women" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:4 [ 0 => "S.M. Handwerker" 1 => "B.T. Altura" 2 => "D.S. Chi" 3 => "B.M. Altura" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:6 [ "tituloSerie" => "Acta Obstet Gynecol Scand" "fecha" => "1995" "volumen" => "74" "paginaInicial" => "517" "paginaFinal" => "519" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/7618448" "web" => "Medline" ] ] ] ] ] ] ] ] 36 => array:3 [ "identificador" => "bib0185" "etiqueta" => "37" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Feasibility of short-term infusion of magnesium sulfate in pediatric patients with <span class="elsevierStyleItalic">status asthmaticus</span>" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:4 [ 0 => "J. Irazuzta" 1 => "T. Egelund" 2 => "S.K. Wassil" 3 => "C. Hampp" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.5863/1551-6776-17.2.150" "Revista" => array:6 [ "tituloSerie" => "J Pediatr Pharmacol Ther" "fecha" => "2012" "volumen" => "17" "paginaInicial" => "150" "paginaFinal" => "154" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/23118666" "web" => "Medline" ] ] ] ] ] ] ] ] 37 => array:3 [ "identificador" => "bib0190" "etiqueta" => "38" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "High-dose magnesium sulfate infusion protocol for <span class="elsevierStyleItalic">status asthmaticus</span>: a safety and pharmacokinetics cohort study" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:5 [ 0 => "T.A. Egelund" 1 => "S.K. Wassil" 2 => "E.M. Edwards" 3 => "S. Linden" 4 => "J.E. Irazuzta" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1007/s00134-012-2734-6" "Revista" => array:6 [ "tituloSerie" => "Intensive Care Med" "fecha" => "2012" "volumen" => "39" "paginaInicial" => "117" "paginaFinal" => "122" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/23129148" "web" => "Medline" ] ] ] ] ] ] ] ] 38 => array:3 [ "identificador" => "bib0195" "etiqueta" => "39" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "High-dose magnesium sulfate infusion for severe asthma in the emergency department" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:4 [ 0 => "J.E. Irazuzta" 1 => "F. Paredes" 2 => "V. Pavlicich" 3 => "S.L. Dominguez" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:5 [ "tituloSerie" => "Pediatr Crit Care Med" "fecha" => "2016" "volumen" => "17" "paginaInicial" => "29" "paginaFinal" => "33" ] ] ] ] ] ] 39 => array:3 [ "identificador" => "bib0200" "etiqueta" => "40" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Comparison of two high-dose magnesium infusion regimens in the treatment of <span class="elsevierStyleItalic">status asthmaticus</span>" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:2 [ 0 => "D. Vaiyani" 1 => "J.E. Irazuzta" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.5863/1551-6776-21.3.233" "Revista" => array:6 [ "tituloSerie" => "J Pediatr Pharmacol Ther" "fecha" => "2016" "volumen" => "21" "paginaInicial" => "233" "paginaFinal" => "238" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/27453701" "web" => "Medline" ] ] ] ] ] ] ] ] 40 => array:3 [ "identificador" => "bib0205" "etiqueta" => "41" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Magnesium sulfate for severe acute asthma in children" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:1 [ 0 => "H.W. Kelly" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:4 [ "tituloSerie" => "J Pediatr Pharmacol Ther" "fecha" => "2003" "volumen" => "8" "paginaInicial" => "4045" ] ] ] ] ] ] 41 => array:3 [ "identificador" => "bib0210" "etiqueta" => "42" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Magnesium toxicity as a cause of hypotension and hypoventilation" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:1 [ 0 => "C.A. Fassler" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:6 [ "tituloSerie" => "Arch Intern Med" "fecha" => "1985" "volumen" => "145" "paginaInicial" => "1604" "paginaFinal" => "1606" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/4026491" "web" => "Medline" ] ] ] ] ] ] ] ] 42 => array:3 [ "identificador" => "bib0215" "etiqueta" => "43" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Method specificity of non-invasive blood pressure measurement: oscillometry and finger pulse pressure <span class="elsevierStyleItalic">vs</span> acoustic methods" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:5 [ 0 => "C. Mey" 1 => "V. Schroeter" 2 => "R. Butzer" 3 => "S. Roll" 4 => "G. Belz" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:6 [ "tituloSerie" => "Br J Clin Pharmacol" "fecha" => "1995" "volumen" => "40" "paginaInicial" => "291" "paginaFinal" => "297" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/8554929" "web" => "Medline" ] ] ] ] ] ] ] ] 43 => array:3 [ "identificador" => "bib0220" "etiqueta" => "44" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Obesity and asthma" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:3 [ 0 => "D.A. Beuther" 1 => "S.T. Weiss" 2 => "E.R. Sutherland" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1164/rccm.200602-231PP" "Revista" => array:6 [ "tituloSerie" => "Am J Resp Crit Care Med" "fecha" => "2006" "volumen" => "174" "paginaInicial" => "112" "paginaFinal" => "119" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/16627866" "web" => "Medline" ] ] ] ] ] ] ] ] 44 => array:3 [ "identificador" => "bib0225" "etiqueta" => "45" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Effect of exercise test on pulmonary function of obese adolescents" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "A.G. Faria" 1 => "M.A. Ribeiro" 2 => "F.A. Marson" 3 => "C.I. Schivinski" 4 => "S.D. Severino" 5 => "J.D. Ribeiro" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:5 [ "tituloSerie" => "J Pediatr" "fecha" => "2014" "volumen" => "90" "paginaInicial" => "242" "paginaFinal" => "249" ] ] ] ] ] ] 45 => array:3 [ "identificador" => "bib0230" "etiqueta" => "46" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Inhaled magnesium sulfate in the treatment of acute asthma" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "C. Powell" 1 => "K. Dwan" 2 => "S.J. Milan" 3 => "R. Beasley" 4 => "R. Hughes" 5 => "J.A. Knopp-Sihota" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1002/14651858.CD003898.pub5" "Revista" => array:5 [ "tituloSerie" => "Cochrane Database Syst Rev" "fecha" => "2012" "volumen" => "12" "paginaInicial" => "CD003898" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/23235599" "web" => "Medline" ] ] ] ] ] ] ] ] ] ] ] ] ] "idiomaDefecto" => "en" "url" => "/00217557/00000093000000S1/v1_201711110016/S0021755717305399/v1_201711110016/en/main.assets" "Apartado" => array:4 [ "identificador" => "10176" "tipo" => "SECCION" "en" => array:2 [ "titulo" => "Review articles" "idiomaDefecto" => true ] "idiomaDefecto" => "en" ] "PDF" => "https://static.elsevier.es/multimedia/00217557/00000093000000S1/v1_201711110016/S0021755717305399/v1_201711110016/en/main.pdf?idApp=UINPBA000049&text.app=https://jped.elsevier.es/" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S0021755717305399?idApp=UINPBA000049" ]
Year/Month | Html | Total | |
---|---|---|---|
2024 November | 24 | 6 | 30 |
2024 October | 67 | 38 | 105 |
2024 September | 84 | 56 | 140 |
2024 August | 104 | 41 | 145 |
2024 July | 107 | 75 | 182 |
2024 June | 69 | 45 | 114 |
2024 May | 92 | 21 | 113 |
2024 April | 88 | 38 | 126 |
2024 March | 86 | 29 | 115 |
2024 February | 83 | 31 | 114 |
2024 January | 173 | 33 | 206 |
2023 December | 134 | 34 | 168 |
2023 November | 132 | 46 | 178 |
2023 October | 170 | 61 | 231 |
2023 September | 99 | 48 | 147 |
2023 August | 41 | 29 | 70 |
2023 July | 43 | 27 | 70 |
2023 June | 21 | 14 | 35 |
2023 May | 57 | 24 | 81 |
2023 April | 42 | 13 | 55 |
2023 March | 51 | 28 | 79 |
2023 February | 41 | 22 | 63 |
2023 January | 52 | 22 | 74 |
2022 December | 72 | 31 | 103 |
2022 November | 55 | 24 | 79 |
2022 October | 84 | 42 | 126 |
2022 September | 44 | 49 | 93 |
2022 August | 46 | 36 | 82 |
2022 July | 68 | 43 | 111 |
2022 June | 48 | 33 | 81 |
2022 May | 75 | 36 | 111 |
2022 April | 129 | 44 | 173 |
2022 March | 76 | 50 | 126 |
2022 February | 44 | 27 | 71 |
2022 January | 51 | 29 | 80 |
2021 December | 38 | 27 | 65 |
2021 November | 32 | 26 | 58 |
2021 October | 21 | 33 | 54 |
2021 September | 23 | 18 | 41 |
2021 August | 15 | 8 | 23 |
2021 July | 20 | 13 | 33 |
2021 June | 22 | 24 | 46 |
2021 May | 21 | 26 | 47 |
2021 April | 81 | 47 | 128 |
2021 March | 22 | 26 | 48 |
2021 February | 18 | 8 | 26 |
2021 January | 18 | 13 | 31 |
2020 December | 11 | 19 | 30 |
2020 November | 10 | 7 | 17 |
2020 October | 8 | 7 | 15 |
2020 September | 12 | 17 | 29 |
2020 August | 5 | 0 | 5 |
2020 July | 9 | 2 | 11 |
2020 June | 8 | 4 | 12 |
2020 May | 11 | 7 | 18 |
2020 April | 34 | 20 | 54 |
2020 March | 17 | 2 | 19 |
2020 February | 19 | 10 | 29 |
2020 January | 16 | 11 | 27 |
2019 December | 13 | 7 | 20 |
2019 November | 7 | 10 | 17 |
2019 October | 15 | 14 | 29 |
2019 September | 12 | 13 | 25 |
2019 August | 19 | 15 | 34 |
2019 July | 11 | 11 | 22 |
2019 June | 13 | 19 | 32 |
2019 May | 17 | 18 | 35 |
2019 April | 18 | 13 | 31 |
2019 March | 9 | 6 | 15 |
2019 February | 14 | 6 | 20 |
2019 January | 9 | 11 | 20 |
2018 December | 13 | 4 | 17 |
2018 November | 29 | 6 | 35 |
2018 October | 149 | 25 | 174 |
2018 September | 7 | 8 | 15 |
2018 August | 2 | 12 | 14 |
2018 July | 11 | 10 | 21 |
2018 June | 8 | 23 | 31 |
2018 May | 10 | 57 | 67 |
2018 April | 11 | 5 | 16 |
2018 March | 16 | 8 | 24 |
2018 February | 11 | 15 | 26 |
2018 January | 15 | 5 | 20 |
2017 December | 4 | 5 | 9 |
2017 November | 11 | 3 | 14 |
2017 October | 3 | 7 | 10 |
2017 September | 0 | 10 | 10 |
2017 August | 0 | 12 | 12 |